Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of MEF2A and SLC22A3-LPAL2-LPA gene polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients.

PloS one - 1 Jan 2023

Al-Eitan Laith N, Almasri Ayah Y, Alnaamneh Adan H, Mihyar Ahmad

Abstract excerpt

AIMS: This study aims to investigate the influence of MEF2A and SLC22A3-LPAL2-LPA polymorphisms on cardiovascular disease susceptibility and responsiveness to warfarin medication in Jordanian patients, during the initiation and maintenance phases of treatment. BACKGROUNDS: Several candidate genes have been reported to be involved in warfarin metabolism and studying such genes may help in finding an accurate way...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance

Share to Jordan

Share to Lipoprotein(a)

Share to MEF2 Transcription Factors

Share to Metabolism, Inborn Errors

Share to Warfarin

Source

Open in PubMed Open full text

Identifiers

PMID: 37948393
DOI: 10.1371/journal.pone.0294226
PMCID: PMC10637663

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of MEF2A and SLC22A3-LPAL2-LPA gene polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients.PMID 37948393Read ↗

Influence of CYP4F2, ApoE, and CYP2A6 gene polymorphisms on the variability of Warfarin dosage requirements and susceptibility to cardiovascular disease in Jordan.Semantic proximity Read ↗

Impact of CYP2C9 and VKORC1 Polymorphisms on Warfarin Sensitivity and Responsiveness in Jordanian Cardiovascular Patients during the Initiation TherapySemantic proximity Read ↗

Effects of CYP2C9 and VKORC1 polymorphisms on warfarin sensitivity and responsiveness during the stabilization phase of therapySemantic proximity Read ↗

Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese.Semantic proximity Read ↗

The association of Cytochrome 4F2 rs2108622 genetic variant and non-genetic factors with essential hypertension among Jordanian patients attending the University of Jordan Hospital.Semantic proximity Read ↗

Contribution of the ACE (rs1799752) and CYP11B2 (rs1799998) Gene Polymorphisms to Atrial Fibrillation in the Tunisian Population.Semantic proximity Read ↗

Predictors of Anticoagulant Treatment Control in New Warfarin Patients in JordanSemantic proximity Read ↗

Effects of vitamin K epoxide reductase complex 1 gene polymorphisms on warfarin control in Japanese patients with left ventricular assist devices (LVAD).Semantic proximity Read ↗

How the cytochrome 7a1 (CYP7A1) and ATP-binding cassette G8 (ABCG8) genetic variants affect atorvastatin response among type 2 diabetic patients attending the University of Jordan Hospital.Semantic proximity Read ↗

Association of DDAH2 gene polymorphism with cardiovascular disease in Egyptian patients.Semantic proximity Read ↗

Lack of association between the Cytochrome P450 4F2 rs2108622 genotype and responses to valsartan and amlodipine among a sample of Jordanian hypertensive patients.Semantic proximity Read ↗

An algorithm for managing warfarin resistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.